KALIURETIC EFFECT OF L-DOPA TREATMENT IN PARKINSONIAN PATIENTS

被引：0
|
作者：
GRANERUS, AK
JAGENBURG, R
SVANBORG, A
机构：
[1] VASA HOSP, GERIAT CLIN LONG TERM CARE 2, GOTEBORG, SWEDEN
[2] UNIV GOTHENBURG, SAHLGRENS HOSP, DEPT CLIN CHEM, S-41345 GOTHENBURG, SWEDEN
来源：
ACTA MEDICA SCANDINAVICA | 1977年 / 201卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：291 / 297
页数：7
相关论文
共 50 条
  • [21] PARKINSONIAN SYNDROMES - TREATMENT BY ASSOCIATION OF L-DOPA PLUS DECARBOXYLASE INHIBITOR
    GAUTHIER, G
    JUGE, O
    BIRCHLER, A
    [J]. EUROPEAN NEUROLOGY, 1974, 11 (03) : 133 - 157
  • [22] NIACIN DEPLETION IN PARKINSONIAN PATIENTS TREATED WITH L-DOPA, BENSERAZIDE AND CARBIDOPA
    BENDER, DA
    EARL, CJ
    LEES, AJ
    [J]. CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1979, 56 (01): : 89 - 93
  • [23] PSYCHOMOTOR EFFECTS OF L-DOPA COMBINED WITH A DECARBOXYLASE INHIBITOR ON PARKINSONIAN PATIENTS
    KLAIBER, B
    SIEGFRIE.J
    ZIEGLER, WH
    PERRET, E
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1971, 3 (03) : 172 - &
  • [24] ELECTRORETINOGRAMS AND VISUAL EVOKED CORTICAL POTENTIALS IN PARKINSONIAN-PATIENTS WITH OR WITHOUT L-DOPA TREATMENT
    GELMI, C
    SANDRINI, G
    MARTIGNONI, E
    BRUNO, A
    NAPPI, G
    TRIMARCHI, F
    [J]. NEURO-OPHTHALMOLOGY, 1992, 12 (02) : 125 - 132
  • [25] EFFECT OF L-DOPA TREATMENT ON SPEECH OF PATIENTS WITH PARKINSONS DISEASE
    ADELMAN, JU
    HOEL, RL
    LASSMAN, FM
    [J]. NEUROLOGY, 1970, 20 (04) : 410 - &
  • [26] Calcium homeostasis is dysregulated in parkinsonian patients with L-Dopa induced dyskinesias
    Blandini, F.
    Bazzini, E.
    Marino, F.
    Saporiti, F.
    Armentero, M. -T.
    Pacchetti, C.
    Zangaglia, R.
    Martignoni, E.
    Lecchini, S.
    Nappi, G.
    Cosentino, M.
    [J]. MOVEMENT DISORDERS, 2008, 23 (01) : S88 - S88
  • [27] OCCURRENCE OF A NEW CLASS OF TETRAHYDROISOQUINOLINES IN L-DOPA TREATED PARKINSONIAN PATIENTS
    COSCIA, CJ
    BURKE, W
    JAMROZ, G
    KOSLOFF, A
    MCFARLANE, J
    MITCHELL, J
    WILSON, ML
    [J]. FEDERATION PROCEEDINGS, 1977, 36 (03) : 804 - 804
  • [28] THE EFFECT OF L-DOPA INFUSIONS WITH AND WITHOUT PHENYLALANINE CHALLENGES IN PARKINSONIAN-PATIENTS - PLASMA AND VENTRICULAR CSF L-DOPA LEVELS AND CLINICAL-RESPONSES
    WOODWARD, WR
    OLANOW, CW
    BECKNER, RM
    HAUSER, RA
    GAUGER, LL
    CEDARBAUM, JM
    NUTT, JG
    [J]. NEUROLOGY, 1993, 43 (09) : 1704 - 1708
  • [29] MECHANISM OF NULLIFICATION OF CNS EFFECTS OF L-DOPA BY PYRIDOXINE IN PARKINSONIAN PATIENTS
    PFEIFFER, R
    EBADI, M
    [J]. JOURNAL OF NEUROCHEMISTRY, 1972, 19 (09) : 2175 - +
  • [30] Calcium homeostasis is dysregulated in parkinsonian patients with L-dopa induced dyskinesias
    Blandini, F.
    Bazzini, E.
    Marino, F.
    Saporiti, F.
    Armentero, M. T.
    Pacchetti, C.
    Zangaglia, R.
    Martignoni, E.
    Lecchini, S.
    Nappi, G.
    Cosentino, M.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 : 102 - 103
12345